The post Charles Hoskinson doubts CLARITY Act progress, urges Trump’s crypto czar to step down appeared on BitcoinEthereumNews.com. Cardano founder Charles HoskinsonThe post Charles Hoskinson doubts CLARITY Act progress, urges Trump’s crypto czar to step down appeared on BitcoinEthereumNews.com. Cardano founder Charles Hoskinson

Charles Hoskinson doubts CLARITY Act progress, urges Trump’s crypto czar to step down

Cardano founder Charles Hoskinson expressed his doubts on Sunday regarding the timeline of the U.S. Digital Asset Market CLARITY Act. He also called for the resignation of President Donald Trump’s crypto czar, David Sacks. 

The crypto mogul argued that Sacks will not be able to pass the digital asset legislation by the first quarter of 2026. He also believes that the bill will be impossible to pass if Democrats regain control of the U.S. House of Representatives in November’s midterm elections.

Hoskinson believes U.S. crypto policy is failing

Hoskinson said in an interview with crypto enthusiast Scott Melker on The Wolf of All Street that the Trump administration’s crypto advisor has failed the crypto industry. He argued that Sacks has nothing to show for his position as crypto czar since taking on the role in late 2024.

The founder of Cardano argued that Sacks had failed the crypto industry due to falling crypto prices and the lack of regulatory clarity. He also stated that the crypto czar has failed to establish a strong foundation for building projects in the industry.

Hoskinson argued that he was judging Sacks based on his track record since he is the one in charge of the crypto industry. He noted that most digital assets have dropped by 40%-50% since Trump resumed office in January 2025. He maintained that the falling prices prove that the crypto industry is unhealthy.

The CLARITY Act was introduced in May 2025 and passed the House Financial Services Committee and the House Agriculture Committee with bipartisan support. The legislation aims to clarify crypto regulation under the Securities and Exchange Commission and the Commodities Futures Trading Commission. The bill also seeks to guide the crypto industry on the different types of digital assets.

The crypto industry is bracing for the upcoming vote on the bill by the Senate Agriculture and Banking Committees on Thursday. The vote will determine the way forward for the CLARITY Act implementation in the industry.

Hoskinson also believes that U.S. crypto policy is failing due to other bills, such as the stablecoin-related GENIUS Act. He argued that the legislation only favors large financial institutions over retail investors. 

The crypto mogul noted that the legislation is centralizing the crypto industry around big firms, including BlackRock, Cantor, Goldman Sachs, and Morgan Stanley. He stated that the Trump administration’s bill essentially handed Wall Street the keys to the crypto industry.

Hoskinson criticized Trump’s crypto ventures 

Hoskinson also argued that U.S. crypto policy is failing due to digital assets tied to the President, such as Trumpcoin. He pointed to the controversial Trump memecoin, urging the U.S. not to favor or nationalize digital assets. 

The crypto mogul warned that cryptocurrency should remain a global and neutral product. Hoskinson maintained that there’s no such thing as American crypto protocols, but there can be American cryptocurrency companies. 

Hoskinson stated in December that Trump’s cryptocurrency ventures had created a huge market disruption. He also believes that the President may be subpoenaed when the Democrats get back in power. The crypto mogul also criticized the timing of Trump’s family-linked crypto project, World Liberty Financial.

Cardano’s founder also called for a clear and careful establishment of crypto laws. He believes the U.S. government should unite with the crypto industry rather than rushing for partisan gain. Hoskinson stated that the goal of the U.S. should be to pass regulations that last and don’t limit innovation, even if it takes longer to make it happen.

Claim your free seat in an exclusive crypto trading community – limited to 1,000 members.

Source: https://www.cryptopolitan.com/charles-hoskinson-doubts-clarity-act/

Market Opportunity
The AI Prophecy Logo
The AI Prophecy Price(ACT)
$0.02599
$0.02599$0.02599
-1.10%
USD
The AI Prophecy (ACT) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23